3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with 5-fluorodopamine in 1 studies
Studies (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Trials (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Recent Studies (post-2010) (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Studies (5-fluorodopamine) | Trials (5-fluorodopamine) | Recent Studies (post-2010) (5-fluorodopamine) |
---|---|---|---|---|---|
330 | 40 | 33 | 76 | 8 | 16 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brücke, T; Chiueh, CC; Cohen, RM; Kung, HF; McLellan, CA; Singhaniyom, W; Tsai, YF | 1 |
1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and 5-fluorodopamine
Article | Year |
---|---|
Blockade of in vivo binding of 125I-labeled 3-iodobenzamide (IBZM) to dopamine receptors by D2 antagonist and agonist.
Topics: Animals; Autoradiography; Benzamides; Binding, Competitive; Caudate Nucleus; Dopamine; Ergolines; Mice; Mice, Inbred C57BL; Nucleus Accumbens; Olfactory Bulb; Pyrrolidines; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D2; Septal Nuclei | 1988 |